Friday, June 21, 2019 9:01:52 AM
LAHO! GSCG massive growth!
June 20, 2019...
..the Regenerative Medicine (RM) Industry has been rapidly expanding in recent years, making it a high-value, fast-growth market..Big Pharma is also demonstrating a snowballing interest in regenerative medicine.
The Regenerative Medicine (RM) Industry includes companies that are developing:
Stem cell therapies
Cellular therapies
Gene therapies
Tissue engineering
Direct cell reprogramming
Exosome therapies
Cellular scaffolds and matrices
3D bioprinting
Biomaterials
Combination Products
And More
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
...This upsurge in venture capital investment represents growth of 7,300% over an eight-year period.
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
..The Global Stem Cells Group is a stand out from many companies in the stem cell medicine arena in that we focus on serving our clients by delivering the most relevant cutting edge solutions. We are committed to balancing competitive pricing and providing solid economic gains for our shareholders. By providing the best cellular medicine services available, we believe that we are building a company that will create more value for our customers and our stockholders.
We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
http://www.stemcellsgroup.com/investor-relations/
The Stem Cell Group
?@StemCellGroupUS
18h18 hours ago
CIRM Board Approves New Clinical Trial for Rare Childhood Disease
https://twitter.com/StemCellGroupUS
Adimarket, Certs, Training, Technology, stem cells.. money maker!
$LAHO GSCG
June 20, 2019...
..the Regenerative Medicine (RM) Industry has been rapidly expanding in recent years, making it a high-value, fast-growth market..Big Pharma is also demonstrating a snowballing interest in regenerative medicine.
The Regenerative Medicine (RM) Industry includes companies that are developing:
Stem cell therapies
Cellular therapies
Gene therapies
Tissue engineering
Direct cell reprogramming
Exosome therapies
Cellular scaffolds and matrices
3D bioprinting
Biomaterials
Combination Products
And More
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
...This upsurge in venture capital investment represents growth of 7,300% over an eight-year period.
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue.
http://www.stemcellsgroup.com/tag/3d-bioprinnting/
..The Global Stem Cells Group is a stand out from many companies in the stem cell medicine arena in that we focus on serving our clients by delivering the most relevant cutting edge solutions. We are committed to balancing competitive pricing and providing solid economic gains for our shareholders. By providing the best cellular medicine services available, we believe that we are building a company that will create more value for our customers and our stockholders.
We pledge to adhere to the highest standards of integrity on behalf of our customers, our stockholders, and the world. We have created the optimal corporate structure to realize Global Stem Cell Group’s long-term potential, and we have established the appropriate financial controls and management oversight of our internal processes.
http://www.stemcellsgroup.com/investor-relations/
The Stem Cell Group
?@StemCellGroupUS
18h18 hours ago
CIRM Board Approves New Clinical Trial for Rare Childhood Disease
https://twitter.com/StemCellGroupUS
Adimarket, Certs, Training, Technology, stem cells.. money maker!
$LAHO GSCG
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
